Sab Biotherapeutics Inc share price logo

Sab Biotherapeutics Inc Share Price

NASDAQ: SABS

$3.52

-0.28

(-7.37%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app

Sab Biotherapeutics Inc Stock Performance

as on April 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.53
    $3.75
    downward going graph

    -0.28%

    Downside

    6.53%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.44
    $6.60
    downward going graph

    59.09%

    Downside

    87.50%

    Upside

    downward going graph

Sab Biotherapeutics Inc share price movements today

Previous Close
$3.80
Open
$3.71
Volume
1.3M
Day's Low - High
$3.53 - $3.75
52 Week Low - High
$1.44 - $6.60

Sab Biotherapeutics Inc Historical Returns

1 Month Return
-0.52 %
3 Month Return
-5.94 %
1 Year Return
+ 117.14 %
3 Year Return
-50.97 %
5 Year Return
0 %

Sab Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Sab Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Sab Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sab Biotherapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$-NANA0.00%
BUY$-129.51%NA0.00%
BUY$-99.68%NA0.00%
NA$-NANA0.00%
BUY$-56.77%NA0.00%

Stock Returns calculator for Sab Biotherapeutics Inc Stock including INR - Dollar returns

The Sab Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Sab Biotherapeutics Inc investment value today

Current value as on today

₹2,22,129

Returns

₹1,22,129

(+122.13%)

Returns from Sab Biotherapeutics Inc Stock

₹1,01,143 (+101.14%)

Dollar Impact

₹20,986 (+20.99%)

Analyst Recommendation on Sab Biotherapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Sab Biotherapeutics Inc. Average target price of $9.5

Sab Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Sab Biotherapeutics Inc.

What analysts predicted

62.95%UPSIDE

Target Price

$9.5

Current Price

$3.52

Analyzed by

8 Analysts

Target

$9.50

Sab Biotherapeutics Inc target price $9.5, a slight upside of 62.95% compared to current price of $3.52. According to 8 analysts rating.

Sab Biotherapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Sab Biotherapeutics Inc Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-13% versus previous 30 day period

Sab Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
1
0
0
0
0
0
-
-
-
-
Gross Profit
0
0
-1
0
0
0
0
0
0
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-5
-22
-5
-7
-10
-11
-5
-10
45
-16
Net Profit Margin
-402.68%
-7493.83%
-532.06%
-2787.69%
2524246.34%
-9934.52%
0.00%
0.00%
0.00%
0.00%

Sab Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
3
55
60
23
2
1
-
Gross Profit
3
55
59
20
-1
-3
-3
Operating Income
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-8
20
-17
-18
-42
-34
13
Net Profit Margin
-261.07%
36.42%
-28.16%
-78.40%
-1884.50%
-2579.03%
0.00%

Global Institutional Holdings in Sab Biotherapeutics Inc

Funds
Holdings
Tower Research Capital LLC
0.01%
Vivo Capital, LLC
16.25%
Marshall Wace Asset Management Ltd
0.34%
Mccormack Advisors International
0%
StemPoint Capital LP
0.21%

Insights on Sab Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, SABS stock has moved up by 25.4%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SABS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -410.0 → 114.69K (in $), with an average increase of 100.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sab Biotherapeutics Inc has experienced a drawdown of -51.0%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 48.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 45.44M → -16.86M (in $), with an average decrease of 137.1% per quarter

About Sab Biotherapeutics Inc

SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of human polyclonal immunotherapeutic antibodies, or human immunoglobulin G (hIgG), to address immunology disorders. The Company is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets or best-in-class against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. The Company’s lead product candidate, SAB-142, is a human anti-thymocyte globulin (ATG) focused on preventing or delaying the progression of T1D. SAB-142 is expected to reduce autoimmune beta cell destruction and delay progression or onset of T1D in patients with Stage III or Stage II T1D. The Company’s genetic engineering platform produces human, multi-targeted, high-potency immunoglobulins, without the need for human donors or convalescent plasma.
OrganisationSab Biotherapeutics Inc
E-voting on sharesClick here to vote

FAQs

What is Sab Biotherapeutics Inc share price today?

Sab Biotherapeutics Inc share price today is $3.52 as on at the close of the market. Sab Biotherapeutics Inc share today touched a day high of $3.75 and a low of $3.53.

What is the 52 week high and 52 week low for Sab Biotherapeutics Inc share?

Sab Biotherapeutics Inc share touched a 52 week high of $6.6 on and a 52 week low of $1.44 on . Sab Biotherapeutics Inc stock price today i.e. is closed at $3.52,which is 46.67% down from its 52 week high and 144.44% up from its 52 week low.

How to invest in Sab Biotherapeutics Inc Stock (SABS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sab Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sab Biotherapeutics Inc Shares that will get you 0.4261 shares as per Sab Biotherapeutics Inc share price of $3.52 per share as on April 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Sab Biotherapeutics Inc Stock (SABS) from India?

Indian investors can start investing in Sab Biotherapeutics Inc (SABS) shares with as little as ₹94.228 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in Sab Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Sab Biotherapeutics Inc share’s latest price of $3.52 as on April 25, 2026 at 1:29 am IST, you will get 2.8409 shares of Sab Biotherapeutics Inc. Learn more about fractional shares .